ViOptix spies $895K to measure tissue oxygen
ViOptix, maker of a device that measures tissue oxygen levels for various medical applications, has brought in $895,000 in equity and debt, according to a filing with the SEC. Last December, during an especially tough time for biotech companies, it successfully raised $4.4 million, closing its fourth round of financing at $16.6 million.
The Fremont, Calif. company is funded by Canadian Medical Discoveries Fund, Channel Medical Partners and Morningside Technology Ventures, BioAsia Management and Lincoln Funds… Continue Reading
Sanarus raises $3M to battle breast cancer
Sanarus Medical, maker of a device used to diagnose and treat breast cancer, brought in $3 million in convertible note funding from existing investors, reports VentureWire. It’s currently working on a product that uses ultrasound technology to detect the early stages of the disease.
The Pleasanton, Calif. company already has several devices on the market, many of which are based on cryotechnology — basically, the freezing of small, targeted sections of breast tissue — which gives… Continue Reading
ViOptix snags $7.4M to measure tissue oxygen
Biotech firm ViOptix just tacked $4.4 million onto an already $12.2 million fourth round of funding and landed $3 million in debt financing to break even, reports VentureWire. The Fremont, Calif. company says this will be its last round of venture capital.
Around since 1999, ViOptix has pioneered a device that allows doctors to detect how much oxygen exists in human tissues through a non-invasive procedure. No plans for the new money, beyond self-sufficiency, have been… Continue Reading
Life sciences briefing: Thursday, Jan. 10, 2008
TODAY’S HEADLINES:
ViOptix pulls in $12M for tissue-oxygen sensors (release)
Tethys Bioscience raises funding, preps diabetes-prediction test (release)
Synergy Life Sciences closes $143M medical-device fund (release)
Venture-backed Go Fig. files for bankruptcy protection (VentureWire, sub req’d)
Whole-genome sequencer Knome strikes deal with Beijing Genomics Institute (release)
Omeros, inflammation and CNS drug developer, files for $115M IPO (Edgar)
Clinipace, clinical-trial software maker, seeks $2.6M (Triangle Business Journal)
Seno Medical receives $1M from Texas state fund(release)
Cardiovascular Systems pulls in $11M for arterial-plaque device (PE Hub)
Escoublac… Continue Reading
Sanuras, breat tumor device company raises $15M
Sanarus Medical, a Pleasanton, Calif. company that makes a device to treat breast tumors, has raised $15 million in fifth round of funding, according to a regulatory filing cited by PE Week.
Investors included Easton Capital Partners, Alta Partners, Forward Ventures, Channel Medical Partners, Federated Kaufman Fund, Pequot Private Equity and U.S. Venture Partners. The company has now raised around $72 million in funding.
Novare raises $16 million for less invasive surgery instruments
Novare Surgery has raised $16 million in a fourth round of funding to bring its RealHand instruments for “minimally invasive surgery” to market.
The Cupertino start-up said Point Judith Capital and Tudor Investment Corp. led the round of financing and were joined by existing investors Thomas J. Fogarty, Channel Medical Partners, Canaan Partners, Asset Management and new investor Deerfield Partners.
Gina Raimondo, a partner at Point Judith Capital, has been elected to Novare Surgical Systems’ board of… Continue Reading